Estrella Immunopharma (ESLA) Tax Provisions (2022 - 2025)
Estrella Immunopharma (ESLA) posted quarterly Tax Provisions of -$2.7 million for Q4 2025, down 4355693.65% year-over-year from N/an in Q4 2024, and down 322926.35% quarter-over-quarter from $850.0 in Q2 2025.
Estrella Immunopharma (ESLA) Tax Provisions (2022 - 2025) Analysis & Trends
Estrella Immunopharma (ESLA) has reported Tax Provisions for 4 consecutive years, with -$2.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Provisions fell 4355693.65% year-over-year to -$2.7 million; the TTM figure through Dec 2025 stood at -$2.7 million (down 4546.33% YoY), while the FY2025 annual figure was -$2.7 million, down 162609.54% from the prior year.
- Tax Provisions fell to -$2.7 million in Q4 2025 per ESLA's latest filing, from $850.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $80648.0 in Q4 2022 and bottomed at -$2.7 million in Q4 2025.
- Historically, Tax Provisions has averaged -$325102.2 across 4 years, with a median of $1237.5 in 2024.
- On a YoY basis, Tax Provisions climbed as much as 4355693.65% in 2025 and fell as far as 4355693.65% in 2025.
- Estrella Immunopharma's Tax Provisions stood at $80648.0 in 2022, then sank by 49.73% to $40542.0 in 2023, then sank by 99.84% to $63.0 in 2024, then sank by 4355693.65% to -$2.7 million in 2025.
- Business Quant data shows ESLA's Tax Provisions at -$2.7 million in Q4 2025, $850.0 in Q2 2025, and $13.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Estrella Immunopharma | 32.29 Mn | 32.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.74 Mn |
| Jun 30, 2025 | 850.00 |
| Mar 31, 2025 | 13.00 |
| Dec 31, 2024 | 63.00 |
| Sep 30, 2024 | 1,625.00 |
| Jun 30, 2023 | 40,542.00 |
| Mar 31, 2023 | 19,465.00 |
| Dec 31, 2022 | 80,648.00 |